14th week of 2021 patent applcation highlights part 8 |
Patent application number | Title | Published |
20210100857 | HERPES 1 ANTIBODY SYSTEM | 2021-04-08 |
20210100858 | EGFR BINDING MOIETY-PRESENTING BACTERIOPHAGES FOR TUMOUR TREATMENT | 2021-04-08 |
20210100859 | HERPES SIMPLEX VIRUS (HSV) ANTICANCER THERAPIES | 2021-04-08 |
20210100860 | USE OF COMPOSITIONS OF WATER/ALCOHOL EXTRACTS OF ANTRODIA CINNAMOMEA CUT-LOG WOOD CULTIVATED FRUITING BODY AND SOLID-STATE CULTIVATED MYCELIUM AS AUXILIARIES FOR ANTI-CANCER AGENTS | 2021-04-08 |
20210100861 | METHOD FOR EXTRACTING BIOACTIVE INGREDIENT AND BIOACTIVE INGREDIENT OBTAINED THEREBY | 2021-04-08 |
20210100862 | THERAPEUTIC CANNABIS EXTRACTS | 2021-04-08 |
20210100863 | DIETARY SUPPLEMENTS AND METHODS FOR TREATING PAIN AND INFLAMMATION | 2021-04-08 |
20210100864 | METHOD OF CONTINUOUSLY PRODUCING CANNABIDIOL FROM CANNABIS PLANT AND USE THEREOF | 2021-04-08 |
20210100865 | COMPOSITION AND METHODS OF USE FOR IMMUNE SYSTEM SUPPORT | 2021-04-08 |
20210100866 | METHOD OF TREATMENT USING SYNERGISTIC DIETARY SUPPLEMENTS TO RELIEVE PHYSICAL DISCOMFORT AND PAIN, OR MENTAL DISCOMFORT LINKED TO MENSTRUATION | 2021-04-08 |
20210100867 | COMPOSITIONS AND USES OF LOCALLY-APPLIED ANTIMICROBIAL SYNTHETIC CATIONIC POLYPEPTIDE(S) WITH ENHANCED PERFORMANCE AND SAFETY | 2021-04-08 |
20210100868 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING GASTROINTESTINAL DAMAGE ASSOCIATED WITH NSAID THERAPY | 2021-04-08 |
20210100869 | COMPOSITIONS AND METHODS OF USING SAME FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS) | 2021-04-08 |
20210100870 | BONE DISEASE TREATMENT | 2021-04-08 |
20210100871 | USE OF PEPTIDE COMPOUNDS IN TREATING ACUTE PANCREATITIS | 2021-04-08 |
20210100872 | Pharmacological Formulation Comprising Cyclo (HIS-PRO) As Effective Ingredient For Preventing Or Treating Diabetes Mellitus | 2021-04-08 |
20210100873 | TREATMENT OF DEGENERATIVE JOINT DISEASE | 2021-04-08 |
20210100874 | INDUCING CELL DEATH BY HYPERACTIVATION OF MOTILITY NETWORKS | 2021-04-08 |
20210100875 | RESTORATION OF VISUAL RESPONSES BY IN VIVO DELIVERY OF RHODOPSIN NUCLEIC ACIDS | 2021-04-08 |
20210100876 | Method of Treating of Fibroblast Growth Factor 21 (FGF-21) Deficiency | 2021-04-08 |
20210100877 | USE OF IL-22 IN TREATING NECROTIZING ENTEROCOLITIS | 2021-04-08 |
20210100878 | Formulation Including a Combination of beta-Endorphin and Adrenocorticotropic Hormone | 2021-04-08 |
20210100879 | GNE AS A THERAPEUTIC AGENT | 2021-04-08 |
20210100880 | SYSTEM AND METHOD FOR MICRONEEDLE DELIVERY OF MICROENCAPSULATED VACCINE AND BIOACTIVE PROTEINS | 2021-04-08 |
20210100881 | METHODS FOR DIAGNOSING AND TREATING ALZHEIMER'S DISEASE | 2021-04-08 |
20210100882 | AUTOIMMUNE ANTIGENS AND CANCER | 2021-04-08 |
20210100883 | MODIFIED ADENOVIRUSES FOR CANCER VACCINES DEVELOPMENT | 2021-04-08 |
20210100884 | CELLULAR IMMUNITY INDUCING VACCINE | 2021-04-08 |
20210100885 | CELLULAR IMMUNITY INDUCING VACCINE | 2021-04-08 |
20210100886 | WT1 CANCER ANTIGEN PEPTIDES AND PEPTIDE CONJUGATES COMPRISING THE PEPTIDES | 2021-04-08 |
20210100887 | RECOMBINANT FUSION PROTEIN AND IMMUNOGENIC COMPOSITION | 2021-04-08 |
20210100888 | IMMUNOGENIC COMPLEX FOR ELICITING PROTECTIVE IMMUNITY AGAINST GROUP B STREPTOCOCCUS | 2021-04-08 |
20210100889 | PREPARATION OF FLAGELLIN VACCINE ADJUVANT-BASED VACCINE TO INDUCE PRODUCTION OF ANTIBODY RECOGNIZING CONFORMATION OF ANTIGENS, AND APPLICATION THEREOF | 2021-04-08 |
20210100890 | NEW EHV INSERTION SITE UL43 | 2021-04-08 |
20210100891 | Compositions and Methods for Generating an Immune Response to a Flavivirus | 2021-04-08 |
20210100892 | UNIVERSAL VACCINES AGAINST IMMUNOGENS OF PATHOGENIC ORGANISMS THAT PROVIDE ORGANISM-SPECIFIC AND CROSS-GROUP PROTECTION | 2021-04-08 |
20210100893 | RECOMBINANT RSV WITH SILENT MUTATIONS, VACCINES, AND METHODS RELATED THERETO | 2021-04-08 |
20210100894 | METHODS FOR IMMUNIZING PRE-IMMUNE SUBJECTS AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV) | 2021-04-08 |
20210100895 | HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF | 2021-04-08 |
20210100896 | METHODS AND COMPOSITIONS FOR STIMULATING THE IMMUNE SYSTEM | 2021-04-08 |
20210100897 | METHODS FOR THE STIMULATION OF DENDRITIC CELL (DC) PRECURSOR POPULATION "PRE-DC" AND THEIR USES THEREOF | 2021-04-08 |
20210100898 | CATIONIC LIPID VACCINE COMPOSITIONS AND METHODS OF USE | 2021-04-08 |
20210100899 | NOVEL METHODS FOR INDUCING AN IMMUNE RESPONSE | 2021-04-08 |
20210100900 | METHODS FOR REDUCING OR ELIMINATING THE NEED FOR LIPOPROTEIN APHERESIS IN PATIENTS WITH HYPERLIPIDEMIA BY ADMINISTERING ALIROCUMAB | 2021-04-08 |
20210100901 | ENHANCING THE THERAPEUTIC ACTIVITY OF AN IMMUNE CHECKPOINT INHIBITOR | 2021-04-08 |
20210100902 | PROSTATE SPECIFIC MEMBRANE ANTIGEN BINDING PROTEIN | 2021-04-08 |
20210100903 | AQUEOUS PHARMACEUTICAL FORMULATION COMPRISING ANTI-PD-L1 ANTIBODY AVELUMAB | 2021-04-08 |
20210100904 | TOPICAL PHARMACEUTICAL COMPOSITION BASED ON SEMIFLUORINATED ALKANES | 2021-04-08 |
20210100905 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT, AND RELATED PRODUCTS | 2021-04-08 |
20210100906 | METHOD FOR PRODUCING AN OIL-IN-WATER EMULSION, OIL-IN-WATER EMULSION, AND INSTALLATION FOR PRODUCING AN OIL-IN-WATER EMULSION | 2021-04-08 |
20210100907 | DRUG DELIVERY SYSTEMS COMPRISING A NEUROTROPHIC AGENT, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR (FAS) OR FAS LIGAND (FASL) INHIBITOR, A TUMOR NECROSIS FACTOR-ALPHA (TNF-ALPHA) OR TNF RECEPTOR INHIBITOR, A MITOCHONDRIAL PEPTIDE, AN OLIGONUCLEOTIDE, A CHEMOKINE INHIBITOR, OR A CYSTEINE-ASPARTIC PROTEASE INHIBITOR | 2021-04-08 |
20210100908 | DEGRADATION OF BRUTON'S TYROSINE KINASE (BTK) BY CONJUGATION OF BTK INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE | 2021-04-08 |
20210100909 | Polymeric Methylprednisolone Conjugates and Uses Thereof | 2021-04-08 |
20210100910 | MACROMOLECULES | 2021-04-08 |
20210100911 | CHOLIX-DERIVED CARRIERS FOR ORAL DELIVERY OF HETEROLOGOUS PAYLOAD | 2021-04-08 |
20210100912 | ANTIBODY-DRUG CONJUGATE HAVING ACIDIC SELF-STABILIZATION JUNCTION | 2021-04-08 |
20210100913 | ACTIVATABLE ANTI-CD166 ANTIBODIES AND METHODS OF USE THEREOF | 2021-04-08 |
20210100914 | ANTIBODIES | 2021-04-08 |
20210100915 | ANTIBODY CARRIER BASED ON GOLD NANOPARTICLE-APTAMER CONJUGATE AND METHOD OF PREPARING THE SAME | 2021-04-08 |
20210100916 | PREPARATION AND USE OF MITOCHONDRION-TARGETING SELF-ASSEMBLED PROTEIN NANOPARTICLE | 2021-04-08 |
20210100917 | GENE THERAPY FOR DISEASES CAUSED BY UNBALANCED NUCLEOTIDE POOLS INCLUDING MITOCHONDRIAL DNA DEPLETION SYNDROMES | 2021-04-08 |
20210100918 | Intrathecal Delivery of Recombinant Adeno-Associated Virus 9 | 2021-04-08 |
20210100919 | HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS | 2021-04-08 |
20210100920 | METHODS AND AGENTS FOR THE DETECTION AND TREATMENT OF CANCER | 2021-04-08 |
20210100921 | CARTRIDGE AND STERILIZING DEVICE USING SAME | 2021-04-08 |
20210100922 | SYSTEM FOR TRANSPORTING WASHED MEDICAL EQUIPMENT AND PACKING THE WASHED MEDICAL EQUIPMENT IN CONTAINERS IN A STERILE PROCESSING DEPARTMENT | 2021-04-08 |
20210100923 | METHOD AND SYSTEM FOR GENERATING A FRAGRANCE | 2021-04-08 |
20210100924 | Air Purification System | 2021-04-08 |
20210100925 | WOUND DRESSING FOR TREATMENT OF DAMAGED SKIN | 2021-04-08 |
20210100926 | MEDICAL DEVICE, METHOD OF USING AND MAKING THE SAME | 2021-04-08 |
20210100927 | BIOACTIVE POLYMERIC DRESSING FOR ACCELERATED WOUND CLOSURE | 2021-04-08 |
20210100928 | Elastic Biopolymer and Use as a Tissue Adhesive | 2021-04-08 |
20210100929 | FIBRINOGEN COMPOSITION, METHOD AND WOUND ARTICLES | 2021-04-08 |
20210100930 | WHITLOCKITE COATING CONSTRUCTED ON SURFACE OF CALCIUM PHOSPHATE-BASED BIOCERAMIC SUBSTRATE AND PREPARATION METHOD THEREFOR | 2021-04-08 |
20210100931 | METHODS FOR STABILIZING A BIOPROSTHETIC TISSUE BY CHEMICAL MODIFICATION OF ANTIGENIC CARBOHYDRATES | 2021-04-08 |
20210100932 | ALIGNED ELECTROSPUN MATRICES OF DECELLULARIZED MUSCLE FOR TISSUE REGENERATION | 2021-04-08 |
20210100933 | TISSUE REPAIR LAMINATES | 2021-04-08 |
20210100934 | Phase Change Material for Thermal Therapy and Delivery of Active Ingredients | 2021-04-08 |
20210100935 | ENGINEERED HEPARIN BIOACTIVE MATRIX FOR CLINICAL APPLICATION OF BLOOD CONTACTING SURFACE AND METHOD OF MANUFACTURING THE SAME | 2021-04-08 |
20210100936 | OUTFLOW COLLECTION VESSELS, SYSTEMS, AND COMPONENTS THEREOF FOR HYSTEROSCOPIC SURGICAL PROCEDURES | 2021-04-08 |
20210100937 | ASPIRATION SYSTEMS AND METHODS WITH MULTIPLE PUMPS AND PRESSURE SENSOR | 2021-04-08 |
20210100938 | PERISTALTIC PUMPS WITH REDUCED PULSATIONS | 2021-04-08 |
20210100939 | Limited-Access, Reduced-Pressure Systems And Methods | 2021-04-08 |
20210100940 | REDUCED THROMBOSIS BLOOD PUMP | 2021-04-08 |
20210100941 | COMPOSITIONS AND METHODS FOR REGENERATING CARRIER PROTEIN-CONTAINING MULTIPLE PASS ALBUMIN DIALYSIS FLUID | 2021-04-08 |
20210100942 | PERITONEAL DIALYSATE, PERITONEAL DIALYSATE SET, COMPOSITION USED FOR PERITONEAL DIALYSIS, AND METHOD FOR PERITONEAL DIALYSIS | 2021-04-08 |
20210100943 | Plasmapheresis Methods | 2021-04-08 |
20210100944 | FLUID TEMPERATURE CONTROL DEVICE FOR AN EXTRACORPOREAL BLOOD TREATMENT APPARATUS AND EXTRACORPOREAL BLOOD TREATMENT APPARATUS | 2021-04-08 |
20210100945 | TECHNIQUES FOR DETERMINING PATIENT BLOOD CHARACTERISTCS DURING A DIALYSIS PROCESS | 2021-04-08 |
20210100946 | A CONNECTOR ARRANGEMENT, A SYSTEM FOR EXTRACORPOREAL BLOOD TREATMENT AND A METHOD FOR PRIMING A FLUID CHAMBER OF A BLOOD TREATMENT UNIT | 2021-04-08 |
20210100947 | PERFUSION SYSTEM | 2021-04-08 |
20210100948 | Portable Compact Infusion Device | 2021-04-08 |
20210100949 | SMALL NON-ELECTRICALLY DRIVEN PORTABLE INFUSION DEVICE | 2021-04-08 |
20210100950 | DEVICE AND METHOD FOR IMPROVING RETENTION OF A THERAPY IN THE BLADDER | 2021-04-08 |
20210100951 | CONTROLLER BASED ON LIFESTYLE EVENT DETECTION | 2021-04-08 |
20210100952 | Systems and Methods for Treating Hypoglycemia | 2021-04-08 |
20210100953 | DUAL CHAMBER SYRINGE AND METHODS OF USE THEREOF | 2021-04-08 |
20210100954 | SYSTEM AND METHOD FOR DETECTING APPLIED FORCE DURING INJECTION | 2021-04-08 |
20210100955 | SPRING FOR AN INJECTION DEVICE | 2021-04-08 |
20210100956 | LOW DOSE PREFILLED DRUG DELIVERY DEVICE AND METHOD | 2021-04-08 |